Find the latest Protagonist Therapeutics, Inc. (PTGX) stock quote, history, news and other vital information to help you with your stock trading and. In depth view into PTGX (Protagonist Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Track Protagonist Therapeutics Inc (PTGX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Stock Price Forecast. The 4 analysts with month price forecasts for PTGX stock have an average target of , with a low estimate of 40 and a high estimate. Protagonist Therapeutics (PTGX) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.
Stock price history for Protagonist Therapeutics (PTGX). Highest end of day price: $ USD on Lowest end of day price: $ USD on A high-level overview of Protagonist Therapeutics, Inc. (PTGX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of 0% and %, respectively, for the quarter ended June Do the numbers hold. Earnings Date. 01/01/ EPS EST. EPS PRIOR. EPS. Rev guidance. $10,,, PTGX Stock Price. Upcoming PTGX Catalysts. Drug. Stage. View the real-time PTGX price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. See the latest Protagonist Therapeutics Inc stock price (PTGX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. The current price of PTGX is USD — it has decreased by −% in the past 24 hours. Watch Protagonist Therapeutics, Inc. stock price performance more. Get the latest Protagonist Therapeutics Inc. (PTGX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Protagonist Therapeutics (PTGX) Stock Price Performance. License Error: Access from crawling bot. Protagonist Therapeutics (PTGX) Stock Key Data. Summary. Get the latest updates on Protagonist Therapeutics, Inc. Common Stock (PTGX) after hours trades, after hours share volumes, and more. Get Protagonist Therapeutics Inc (furfamarket.ru) real-time stock quotes, news, price and financial information from Reuters to inform your trading and.
Stock Info · Analyst Coverage · Financials · Governance · Investor Email Alerts Contact Us. +1 () [email protected] Stay Connected. Innovation. Protagonist's stock falls 27% after updating investors about experimental blood disorder drug. Shares of Protagonist Therapeutics Inc. tumbled % in. View Protagonist Therapeutics, Inc. PTGX stock quote prices, financial information, real-time forecasts, and company news from CNN. View today's Protagonist Therapeutics Inc stock price and latest PTGX news and analysis. Create real-time notifications to follow any changes in the live. Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs. PTGX - Protagonist Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGM). Protagonist Therapeutics Inc. ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), $ ; P/E Ratio (TTM), ; Dividend Yield, N/A. On Wednesday 08/28/ the closing price of the Protagonist Therapeutics Inc share was $ on BTT. Compared to the opening price on Wednesday 08/28/ on. Get the latest Protagonist Therapeutics Inc (PTGX) real-time quote, historical performance, charts, and other financial information to help you make more.
Thinking of buying or selling Protagonist Therapeutics Inc stock that's listed in a currency different from your local one? Use our international stock. In the current month, PTGX has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PTGX average Analyst price target in the past 3 months is $ Stock analysis for Protagonist Therapeutics Inc (PTGX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ PTGX will report FY earnings on 03/18/ Yearly Estimates. PTGX, Protagonist Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines.